Department of Health
and Human Services (HHS)
and Human Services (HHS)
November 23, 2020
PAR-18-324 - Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute on Minority Health and Health Disparities (NIMHD)
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI)
The purpose of this Notice is to inform interested applicants of an extension of the expiration date and additional receipt dates added to the Funding Opportunity Announcement (FOA) PAR-18-324: “Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)”. The new receipt dates by application type added to the FOA are: February 5, 2021 for new applications; March 5, 2021 for resubmission or revision applications; and May 7, 2021 for all types of AIDS-related applications. PAR-18-324 will now expire on May 8, 2021.
As a result, the Key Dates section of the FOA has been modified as follows:
Part 1. Overview Information
Key Dates
Currently Reads:
Application Due Date(s)
New applications: February 5, 2018; October 5, 2018; June 5, 2019; February 5, 2020; June 5, 2020, October 5, 2020, by 5:00 PM local time of applicant organization.
Resubmission applications: March 5, 2018; November 5, 2018; July 5, 2019; March 5, 2020; July 5, 2020, November 5, 2020, by 5:00 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
May 7, 2018; January 7, 2019; September 7, 2019; May 7, 2020; September 7, 2020, January 7, 2021, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
Standard dates apply
Advisory Council Review
October 2018; May 2019; January 2020; October 2020; May 2021
Earliest Start Date
Standard dates apply
Expiration Date
January 8, 2021
Modified to Read:
Application Due Date(s)
New applications: February 5, 2018; October 5, 2018; June 5, 2019; February 5, 2020; June 5, 2020, October 5, 2020; February 5, 2021, by 5:00 PM local time of applicant organization.
Resubmission applications: March 5, 2018; November 5, 2018; July 5, 2019; March 5, 2020; July 5, 2020, November 5, 2020; March 5, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
May 7, 2018; January 7, 2019; September 7, 2019; May 7, 2020; September 7, 2020, January 7, 2021; May 7, 2021, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
Standard dates apply
Advisory Council Review
October 2018; May 2019; January 2020; October 2020; May 2021; October 2021
Earliest Start Date
Standard dates apply
Expiration Date
May 8, 2021
All other aspects of this FOA remain the same.
Melissa C. Green Parker, PhD
Office of Disease Prevention (ODP)
Telephone: 301-480-1161
Email: melissa.greenparker@nih.gov